TrialNature medicine2026

Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial.

Lars H Lund et al.PubMed ↗Publisher ↗

No numbers read from the abstract.